Johan Wedell-Wedellsborg
CIK 1753185 · last filed 2025-09-18
Johan Wedell-Wedellsborg is a corporate insider who has filed 28 SEC Form 4 insider transactions across 1 company since 2019. Across all open-market trades the lifetime net is −$21.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
28
-$21.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 4,590,138 | $8.61 | $39.52M | -$21.31M | 27 | 2025-07-02 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | Mixed | −4,590,138 | -$39.26M | |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +25,080 | $0 | EDGAR |
| 2024-06-13 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +3,495 | $0 | EDGAR |
| 2023-12-12 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +6,455 | $44.2K | EDGAR |
| 2023-12-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +127,549 | $890.4K | EDGAR |
| 2023-12-01 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +51,837 | $309.5K | EDGAR |
| 2023-11-29 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +93,187 | $521.3K | EDGAR |
| 2023-06-09 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +2,330 | $0 | EDGAR |
| 2023-05-17 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +101,740 | $981.4K | EDGAR |
| 2022-07-19 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |